Dr. Charles A Thompson
Claim this profileGSK Investigational Site
Studies Flu
Studies Coronavirus
4 reported clinical trials
10 drugs studied
Affiliated Hospitals
Clinical Trials Charles A Thompson is currently running
Donanemab
for Alzheimer's Disease
This trial is testing donanemab, a medication aimed at helping people with Alzheimer's Disease by removing harmful protein clumps from their brains. Donanemab has shown promise in reducing these harmful proteins in Alzheimer's disease.
Recruiting1 award Phase 34 criteria
IHL-42X
for Obstructive Sleep Apnea
The goal of this randomised, double-blind phase II/III clinical trial is to determine the safety and efficacy of IHL-42X in subjects with obstructive sleep apnoea who are intolerant, non-compliant, or naïve to positive airway pressure. Phase II study will be a 4-week dose-finding study comparing two dose strengths of IHL-42X to placebo. The optimal dose strength will be selected based on comparing the safety and efficacy of the two IHL-42X dose strengths to placebo over a 4-week treatment period. The three treatment groups are; IHL-42X Low dose (2.5mg dronabinol, 125mg acetazolamide), IHL-42X High dose (5mg dronabinol, 250mg acetazolamide) and Placebo. Each treatment group will enrol approximately 40 patients per treatment arm, for a total of approximately 120 patients. The safety and efficacy results of the Phase II study will be used to select the dose strength of IHL-42X and corresponding doses of dronabinol and acetazolamide in Phase III. Phase III study will use the optimal dose strength of IHL-42X identified in Phase II and will be compared to the component active pharmaceutical ingredients at equivalent dose strengths to those found in the IHL-42X optimal dose strength and placebo over 52 weeks. The four treatment groups are; IHL-42X (optimal dose from Phase II), Acetazolamide (equivalent dose strength to that in the IHL-42X optimal dose strength), Dronabinol (equivalent dose strength to that in the IHL-42X optimal dose strength) and placebo. The treatment groups will enrol approximately 165 patients in IHL-42X, approximately 55 patients in dronabinol, approximately 55 in acetazolamide, and approximately 165 in placebo, for a total of approximately 440 patients.
Recruiting0 awards Phase 2 & 32 criteria
More about Charles A Thompson
Clinical Trial Related3 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Charles A Thompson has experience with
- FLU Q-PAN H5N8 Formulation 1
- AS03B
- AS03A
- FLU Q-PAN H5N8 Formulation 2
- LY3832479
- LY3853113
Breakdown of trials Charles A Thompson has run
Alzheimer's Disease
Sleep Apnea
Obstructive Sleep Apnea
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Charles A Thompson specialize in?
Charles A Thompson focuses on Flu and Coronavirus. In particular, much of their work with Flu has involved treating patients, or patients who are undergoing treatment.
Is Charles A Thompson currently recruiting for clinical trials?
Yes, Charles A Thompson is currently recruiting for 2 clinical trials in Anderson South Carolina. If you're interested in participating, you should apply.
Are there any treatments that Charles A Thompson has studied deeply?
Yes, Charles A Thompson has studied treatments such as FLU Q-PAN H5N8 Formulation 1, AS03B, AS03A.
What is the best way to schedule an appointment with Charles A Thompson?
Apply for one of the trials that Charles A Thompson is conducting.
What is the office address of Charles A Thompson?
The office of Charles A Thompson is located at: GSK Investigational Site, Anderson, South Carolina 29621 United States. This is the address for their practice at the GSK Investigational Site.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.